Walleye Capital’s NeoGenomics NEO Stock Holding History

Walleye Capital’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,901	Closed	-$30.1K	–	4952
2025 Q3	$30.1K	Buy	3,901 +1,512	+63%	+$10.6K	﹤0.01%	4138
2025 Q2	$17.5K	Sell	2,389 -5,081	-68%	-$41K	﹤0.01%	4253
2025 Q1	$70.9K	Buy	+7,470	New	+$93.3K	﹤0.01%	3744
2024 Q4	–	Sell	-11,330	Closed	-$176K	–	5306
2024 Q3	$167K	Buy	+11,330	New	+$177K	﹤0.01%	4126
2023 Q4	–	Sell	-26,912	Closed	-$331K	–	5325
2023 Q3	$331K	Buy	+26,912	New	+$400K	﹤0.01%	3154
2023 Q1	–	Sell	-2,629	Closed	-$37.5K	–	4226
2022 Q4	$24.3K	Buy	+2,629	New	+$24.5K	﹤0.01%	2633
2022 Q2	–	Sell	-101,264	Closed	-$1.23M	–	2600
2022 Q1	$1.23M	Buy	+101,264	New	+$2.13M	0.03%	541
2019 Q4	–	Sell	-5,000	Closed	-$96K	–	2098
2019 Q3	$96K	Buy	5,000 +4,400	+733%	+$103K	0.01%	1441
2019 Q2	$13K	Buy	+600	New	+$13.2K	﹤0.01%	1572

Other funds holding NEO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Walleye Capital's NEO Position: Q4 2025 in Review

Walleye Capital sold out of NeoGenomics (NEO) in Q4 2025, closing a stake of 3,901 shares — an estimated $30.1K sold.

Walleye Capital first reported a position in NEO in Q2 2019 and held it in 9 quarters. The position peaked at $1.23M in Q1 2022. 256 funds tracked by Wall St. Rank hold NEO as of Q4 2025.

Walleye Capital reported no remaining NeoGenomics position as of Q4 2025 after selling out during the quarter.
Walleye Capital sold 3,901 NeoGenomics shares in Q4 2025, an estimated $30.1K.
Walleye Capital first reported a position in NeoGenomics in Q2 2019 and held it in 9 quarters.
Walleye Capital's NeoGenomics position peaked at $1.23M in Q1 2022.
256 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2025.

Based on Walleye Capital's 13F filing for Q4 2025, filed 13 Feb 2026.